John A Kollins Satsuma Pharmaceuticals, Inc. (STSA) insider trading activity

STSA Quotes by TradingView

John A Kollins is President and CEO of Satsuma Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of STSA, which is worth approximately $0. The most recent transaction as insider was on Jun 06, 2023, when has been sold 305,911 shares (Common Stock, $0.0001 par value) at a price of $0.91 per share, resulting in proceeds of $278,379. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

John A Kollins Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2023
SELL
Disposition due to a tender of shares in a change of control transaction
$278,379 $0.91 p/Share
305,911 Reduced 100.0%
0 Common Stock, $0.0001 ...
JAK

John A Kollins

President and CEO
South San Francisco, CA

Track Institutional and Insider Activities on STSA

Follow Satsuma Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells STSA shares.

Notify only if

Insider Trading

Get notified when an Satsuma Pharmaceuticals, Inc. insider buys or sells STSA shares.

Notify only if

News

Receive news related to Satsuma Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on STSA